Therefore, it is important to delete or downregulate FATS expression only in immune cells, a strategy that could effectively avoid this limitation; in other words, NF-κB signaling could be activated in macrophages with no or low FATS expression without promoting tumor cell activation. This evidence concerns the gene NFKB1 and neoplasm.